k

Tata Motors ropes in Mayank Pareek as head passenger vehicles

Pareek comes with over two decades of experience with Maruti Suzuki where his last role was as COO, wherein he was heading Marketing & Sales vertical.




k

Maruti Suzuki posts highest market share in more than a decade in July

Not only that, the maker of the Alto and WagonR in July produced more vehicles than ever before in its history.




k

Autophagy-focused Casma Therapeutics debuts with $58.5 million from Third Rock

The biotech will first tackle lysosomal storage disorders




k

Merck partners with Moderna to test KRas cancer vaccines in humans

The pair hopes to stimulate the immune system to tackle tumors bearing mutant KRas proteins, one of cancer’s toughest targets




k

Synthorx raises $63 million to make synthetic proteins from an expanded genetic code




k

Evonik buys stake in skin tech start-up mySkin




k

CarbonCure links with Airgas for concrete




k

H.I.G. acquires Brazil’s Elekeiroz




k

Simple guidelines could make designing catalysts for electrochemical reactions easy

Theoretical model uses readily available data to predict catalysts for tackling energy challenges




k

Testing how much trisubstituted amines can bulk up

Using a multitude of methods, chemists make unprecedented crowded alkyl amines; but one elusive target remains out of reach




k

Periwinkle gives up its cancer-busting secrets

Key enzymes in complex biosynthesis could enable alkaloid production




k

CVC to acquire composites maker AOC and link it with Aliancys




k

Crabs gather data with high-tech skin

Flexible, lightweight skin is equipped with sensors, memory, and communications features




k

Evonik keeps the faith in long-term research

German chemical maker seeks to balance technical support and basic R&D that can open new markets




k

Wine sleuths seek answers to the mystery of ‘smoke taint’

As wildfires increase in frequency across the globe, researchers hunt the smoke compounds that can seep into vineyards’ grapes and taint wine




k

Controlling CAR-T: How scientists plan to make the engineered T cell therapy safer, and work for more cancers

CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it




k

Bacteria make a meal of penicillin

Engineered bacteria could be used for bioremediation of antibiotic-contaminated soils




k

Hawaii lawmakers pass ban on sunscreen chemicals oxybenzone and octinoxate

Protecting coral reefs is the legislation’s goal




k

U.S. and U.K. political climates are driving scholars to Canada

‘Brain gain’ program brings high-profile international researchers to Canadian universities




k

Solid body wash comes without packaging. But does that make it eco-friendly?

Cosmetics firms appeal to plastic-free consumers with the hybrid of bar soap and liquid body wash




k

Escient launches to tackle itching and anaphylactoid drug targets

The startup raised $40 million to target a class of GPCRs called Mas-related G-protein receptors, to treat neuroimmune and inflammatory conditions




k

How chemistry helps track and detect nuclear materials

Chemists are designing better methods to analyze confiscated nuclear materials and to track nuclear activity remotely




k

Chemistry in Pictures: Sun-kissed rotovaps




k

Takeda finally snags Shire in $62 billion deal

If successful, the transaction could spur more M&A among major drug firms




k

Hawaii lawmakers pass ban on sunscreen chemicals oxybenzone and octinoxate




k

Environmental groups seek order from North Carolina to stop Chemours pollution




k

Resin maker IGM changes private hands




k

Paul H. Cheek




k

Ruth Lloyd Cheek




k

Merck and Moderna sign cancer vaccine deal




k

Making ACS meetings welcoming portals to the society




k

Succinic acid maker BioAmber is bankrupt




k

German premier Angela Merkel marks Merck’s 350 years




k

Your ducky’s microbiome, glow-in-the-dark squirt guns

Toys inspire biology, biology inspires toys




k

At GP-write, scientists take first steps on way to synthetic human genome

At the third meeting of GP-write, researchers decide to create virus-resistant human cells




k

SOCMA head Jennifer Abril wants to take the trade association back to its roots

The nontraditional leader of the specialty chemical manufacturers’ association wants to steer it back to its traditional values




k

Taking a wider look at tau modifications

Semisynthesis aids study of posttranslational modifications to key Alzheimer’s protein




k

Cosmetics that take on the stresses of modern life

As consumers worry about light and air pollution, personal care formulators look for ways to safeguard skin from blue light and other environmental assaults




k

Can single-cell genomics lead to a new wave of drug targets? Celsius Therapeutics thinks so

The start-up, based on the work of Broad Institute scientist Aviv Regev, has raised $65 million to develop therapies for cancer and autoimmune disease




k

U.S. Army bioengineer develops high-tech fabrics to keep soldiers warm, dry, and safe

Paola D’Angelo discusses how her team develops high-performance textiles to protect and support soldiers on the battlefield




k

Making aluminum without making CO<sub>2</sub>

Apple backs new process that promises oxygen as by-product instead




k

Economy buoys Japanese chemical makers

Strong demand and Chinese environment controls lead to robust earnings




k

Massive Attack’s space-age anniversary and an out-of-this-world vista




k

U.K. builds Graphene City with new innovation center




k

DIC and Checkerspot collaborate on polyols




k

Benson Hill and Beck’s unveil corn yield trait




k

Enerkem gets green light for Spanish waste-to-methanol plant




k

China’s Tianqi to get stake in Chilean lithium maker SQM




k

The good times keep rolling in pharmaceutical chemicals

Exhibitors at CPhI North America report another year of record growth and investment




k

Gilead’s Kite adds cell therapy manufacturing capacity